BiomX Statistics

Share Statistics

BiomX has 26.53M shares outstanding. The number of shares has increased by 46.27% in one year.

Shares Outstanding	26.53M
Shares Change (YoY)	46.27%
Shares Change (QoQ)	4.72%
Owned by Institutions (%)	0.14%
Shares Floating	13.63M
Failed to Deliver (FTD) Shares	4,811
FTD / Avg. Volume	0.09%

Short Selling Information

The latest short interest is 1.55M, so 5.84% of the outstanding shares have been sold short.

Short Interest	1.55M
Short % of Shares Out	5.84%
Short % of Float	5.86%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -2.88 and the forward PE ratio is -0.43. BiomX's PEG ratio is 0.04.

PE Ratio	-2.88
Forward PE	-0.43
PS Ratio	0
Forward PS	0.6
PB Ratio	2.11
P/FCF Ratio	-1.38
PEG Ratio	0.04

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BiomX.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.4.

Current Ratio	2.48
Quick Ratio	2.48
Debt / Equity	0.4
Debt / EBITDA	-0.73
Debt / FCF	-0.26
Interest Coverage	-14.01

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-340.9K
Employee Count	52
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	13K
Effective Tax Rate	-0.07%

Stock Price Statistics

The stock price has increased by -56.3% in the last 52 weeks. The beta is 1.4, so BiomX's price volatility has been higher than the market average.

Beta	1.4
52-Week Price Change	-56.3%
50-Day Moving Average	0.48
200-Day Moving Average	0.59
Relative Strength Index (RSI)	49.97
Average Volume (20 Days)	5,151,782

Income Statement

Revenue	n/a
Gross Profit	-1.8M
Operating Income	-39.03M
Net Income	-17.73M
EBITDA	-13.13M
EBIT	-14.93M
Earnings Per Share (EPS)	-1.47

Full Income Statement

Balance Sheet

The company has 16.86M in cash and 9.58M in debt, giving a net cash position of 7.27M.

Cash & Cash Equivalents	16.86M
Total Debt	9.58M
Net Cash	7.27M
Retained Earnings	-180.7M
Total Assets	38.05M
Working Capital	10.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -36.98M and capital expenditures -30K, giving a free cash flow of -37.01M.

Operating Cash Flow	-36.98M
Capital Expenditures	-30K
Free Cash Flow	-37.01M
FCF Per Share	-0.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for PHGE is $15, which is 2784.6% higher than the current price. The consensus rating is "Buy".

Price Target	$15
Price Target Difference	2784.6%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Aug 26, 2024. It was a backward split with a ratio of 1:10.

Last Split Date	Aug 26, 2024
Split Type	backward
Split Ratio	1:10

Scores

Altman Z-Score	-7.74
Piotroski F-Score	3

BiomX Inc. (PHGE)